Identification of priorities for medication safety in neonatal intensive care

Desireé L Kunac1, David M Reith

  • 1School of Pharmacy, University of Otago, Dunedin, New Zealand. desiree.kunac@stonebow.otago.ac.nz

Drug Safety
|March 1, 2005
PubMed

Insights

Neonatal medication errors are a significant risk. A Failure Mode and Effects Analysis (FMEA) identified lack of training and administration process issues as key vulnerabilities in neonatal intensive care units (NICUs).

Area of Science:

  • Pediatric Patient Safety
  • Health Systems Engineering
  • Neonatal Pharmacology

Background:

  • Neonates face higher medication error risks than older children.
  • Limited understanding of medication error causes in neonates.
  • Failure Mode and Effects Analysis (FMEA) is an industrial safety technique.

Purpose of the Study:

  • To identify and prioritize potential failures in the neonatal intensive care unit (NICU) medication use process.
  • To apply FMEA to enhance medication safety in neonates.

Main Methods:

  • A multidisciplinary panel utilized FMEA and a systems-based approach.
  • Developed a flow diagram of the NICU medication use process.
  • Brainstormed potential failures, causes, and effects, calculating Risk Priority Scores (RPS).

Main Results:

  • Identified 72 failures with 193 causes/effects.
  • Vulnerabilities occurred throughout the process, notably in prescribing and preparation.
  • Top risks included lack of medication safety training (RPS 273) and administration errors (dose, timing, infusion pumps, route).
  • Causes included unsafe preparation/storage systems, variable staff skills, and lack of computerization.

Conclusions:

  • Interventions should increase staff awareness of medication safety.
  • Focusing on medication administration processes is crucial for reducing adverse events in the NICU.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Planning Nursing Care I01:21

Planning Nursing Care I

The planning phase of the nursing process helps nurses set priorities, outline patient-centered goals and expected outcomes, and tailor nursing interventions to align with the aligned care plan. Through the planning phase, the nurse applies critical thinking skills to align and develop interventions according to the patient's needs. It provides continuity of care allowing patients to receive the maximum benefit from treatment. It serves as a pilot plan for allocating individual staff to a...